140 related articles for article (PubMed ID: 37211351)
1. Factors influencing USgHIFU ablation for adenomyosis with NPVR ≥ 50.
Yu JW; Yang MJ; Jiang L; Su XY; Chen JY
Int J Hyperthermia; 2023; 40(1):2211753. PubMed ID: 37211351
[TBL] [Abstract][Full Text] [Related]
2. Comparison efficacy of ultrasound-guided HIFU for adenomyosis-associated dysmenorrhea with different signal intensity on T2-weighted MR imaging.
Yu J; Jiang L; Su X; Yang M; Yang C; Chen J
J Obstet Gynaecol Res; 2023 Apr; 49(4):1189-1197. PubMed ID: 36733261
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: A retrospective study.
Gong C; Yang B; Shi Y; Liu Z; Wan L; Zhang H; Jiang D; Zhang L
Int J Hyperthermia; 2016 Aug; 32(5):496-503. PubMed ID: 27385316
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging features influencing high-intensity focused ultrasound ablation of adenomyosis with a nonperfused volume ratio of ≥90% as a measure of clinical treatment success: retrospective multivariate analysis.
Keserci B; Duc NM
Int J Hyperthermia; 2018; 35(1):626-636. PubMed ID: 30307340
[TBL] [Abstract][Full Text] [Related]
5. Safety of ultrasound-guided high-intensity focused ultrasound ablation for diffuse adenomyosis: A retrospective cohort study.
Feng Y; Hu L; Chen W; Zhang R; Wang X; Chen J
Ultrason Sonochem; 2017 May; 36():139-145. PubMed ID: 28069193
[TBL] [Abstract][Full Text] [Related]
6. A Prediction of NPVR ≥ 80% of Ultrasound-Guided High-Intensity Focused Ultrasound Ablation for Uterine Fibroids.
Yang MJ; Yu RQ; Chen WZ; Chen JY; Wang ZB
Front Surg; 2021; 8():663128. PubMed ID: 34150838
[No Abstract] [Full Text] [Related]
7. Factors affecting effects of ultrasound guided high intensity focused ultrasound for single uterine fibroids: a retrospective analysis.
Fan HJ; Cun JP; Zhao W; Huang JQ; Yi GF; Yao RH; Gao BL; Li XH
Int J Hyperthermia; 2018; 35(1):534-540. PubMed ID: 30428735
[TBL] [Abstract][Full Text] [Related]
8. [Preoperative MR T
Yu J; Yang M; Jiang L; Xiao Z; Li S; Chen J
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Apr; 43(4):597-603. PubMed ID: 37202196
[TBL] [Abstract][Full Text] [Related]
9. Microbubble contrast agent SonoVue combined with oxytocin improves the efficiency of high-intensity focused ultrasound ablation for adenomyosis.
Yao R; Zhao W; Gao B; Hu J; Wang T
Int J Hyperthermia; 2021; 38(1):1601-1608. PubMed ID: 34763594
[TBL] [Abstract][Full Text] [Related]
10. High intensity focused ultrasound treatment of adenomyosis: The relationship between the features of magnetic resonance imaging on T2 weighted images and the therapeutic efficacy.
Gong C; Setzen R; Liu Z; Liu Y; Xie B; Aili A; Zhang L
Eur J Radiol; 2017 Apr; 89():117-122. PubMed ID: 28267526
[TBL] [Abstract][Full Text] [Related]
11. Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid.
Lee JS; Hong GY; Lee KH; Kim TE
BJOG; 2017 Aug; 124 Suppl 3():18-22. PubMed ID: 28856867
[TBL] [Abstract][Full Text] [Related]
12. Tolerance and efficacy of HIFU ablation for uterine fibroids NPVR ≥ 90%: a nested case-control study.
Gong X; Liu D; Yang MJ; Zhang R; Chen WZ; Chen JY
Int J Hyperthermia; 2022; 39(1):946-951. PubMed ID: 35853723
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of high intensity focused ultrasound treatment for different types of adenomyosis based on magnetic resonance imaging classification.
Gong C; Wang Y; Lv F; Zhang L; Wang Z
Int J Hyperthermia; 2022; 39(1):530-538. PubMed ID: 35300545
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of conventional MRI combined with radiomics in the immediate ablation rate of HIFU treatment for uterine fibroids.
Wei C; Li N; Shi B; Wang C; Wu Y; Lin T; Chen Y; Ge Y; Yu Y; Dong J
Int J Hyperthermia; 2022; 39(1):475-484. PubMed ID: 35271784
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-guided high-intensity focused ultrasound in the treatment of uterine fibroids.
Fan HJ; Zhang C; Lei HT; Cun JP; Zhao W; Huang JQ; Zhai Y
Medicine (Baltimore); 2019 Mar; 98(10):e14566. PubMed ID: 30855440
[TBL] [Abstract][Full Text] [Related]
16. Non-contrast enhanced MRI for efficiency evaluation of high-intensity focused ultrasound in adenomyosis ablation.
Si M; Lv F; Tang M; Liu Y; Qiu X; Gong C; Hu Y; Liu Y
Int J Hyperthermia; 2024; 41(1):2295813. PubMed ID: 38234000
[TBL] [Abstract][Full Text] [Related]
17. The safety and ablation efficacy of ultrasound-guided high-intensity focused ultrasound ablation for desmoid tumors.
Zhang R; Chen JY; Zhang L; Li KQ; Xiao ZB; Mo SJ; Chen L; Chen WZ
Int J Hyperthermia; 2021 Sep; 38(2):89-95. PubMed ID: 34420439
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Dose and Effectiveness of a Single-Session Ultrasound-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids With Different Sizes.
Yang MJ; Yu RQ; Chen JY; Wang ZB
Front Oncol; 2021; 11():725193. PubMed ID: 34993130
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of quantitative DCE metrics for immediate therapeutic response of high-intensity focused ultrasound ablation (HIFU) of symptomatic uterine fibroids.
Wei C; Fang X; Wang CB; Chen Y; Xu X; Dong JN
Abdom Radiol (NY); 2018 Aug; 43(8):2169-2175. PubMed ID: 29204677
[TBL] [Abstract][Full Text] [Related]
20. Effect of pre-treatment with gonadotropin-releasing hormone analogue GnRH-α on high-intensity focussed ultrasound ablation for diffuse adenomyosis: a preliminary study.
Xiao-Ying Z; Ying-Shu G; Jiu-Mei C; Jin-Juan W; Hong Y; Chun-Yi Z; Hua D
Int J Hyperthermia; 2018 Dec; 34(8):1289-1297. PubMed ID: 29447020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
